Read + Share
Amedeo Smart
Independent Medical Education
Zervantonakis IK, Poskus MD, Scott AL, Selfors LM, et al. Fibroblast-tumor cell signaling limits HER2 kinase therapy response via activation of MTOR and antiapoptotic pathways. Proc Natl Acad Sci U S A 2020;117:16500-16508.PMID: 32601199
Email
LinkedIn
Facebook
Twitter
Privacy Policy